Allogene Therapeutics
ALLO
Last Price
52 Week Range
$0.86 - $2.80
Next Earnings Date
May 12 2026 (Estimate)
Next Earnings Date
May 12 2026 (Est.)
Last Price
Allogene Therapeutics SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Allogene Therapeutics, Inc. | 10-K | March 12, 2026 | |
Allogene Therapeutics, Inc. | 8-K | March 12, 2026 | |
Allogene Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Allogene Therapeutics, Inc. | 8-K | November 6, 2025 | |
Allogene Therapeutics, Inc. | 8-K | October 14, 2025 | |
Allogene Therapeutics, Inc. | 10-Q | August 13, 2025 | |
Allogene Therapeutics, Inc. | 8-K | August 13, 2025 | |
Allogene Therapeutics, Inc. | 8-K | August 1, 2025 | |
Allogene Therapeutics, Inc. | 8-K | June 23, 2025 | |
Allogene Therapeutics, Inc. | 8-K | May 13, 2025 | |
Allogene Therapeutics, Inc. | 10-Q | May 13, 2025 | |
Allogene Therapeutics, Inc. | ARS | April 30, 2025 | |
Allogene Therapeutics, Inc. | DEF 14A | April 30, 2025 | |
Allogene Therapeutics, Inc. | DEFA14A | April 30, 2025 | |
Allogene Therapeutics, Inc. | 8-K | March 13, 2025 | |
Allogene Therapeutics, Inc. | 10-K | March 13, 2025 | |
Allogene Therapeutics, Inc. | 8-K | February 25, 2025 | |
Allogene Therapeutics, Inc. | 8-K | January 29, 2025 | |
Allogene Therapeutics, Inc. | 8-K | November 13, 2024 | |
Allogene Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Allogene Therapeutics, Inc. | 8-K | November 7, 2024 | |
Allogene Therapeutics, Inc. | 8-K | October 7, 2024 | |
Allogene Therapeutics, Inc. | 8-K | August 7, 2024 | |
Allogene Therapeutics, Inc. | 10-Q | August 7, 2024 | |
Allogene Therapeutics, Inc. | 8-K | June 10, 2024 | |
Allogene Therapeutics, Inc. | 8-K | May 31, 2024 | |
Allogene Therapeutics, Inc. | 8-K | May 14, 2024 | |
Allogene Therapeutics, Inc. | 10-Q | May 13, 2024 | |
Allogene Therapeutics, Inc. | 8-K | May 13, 2024 | |
Allogene Therapeutics, Inc. | DEF 14A | April 23, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.